Cargando…

Effects of lockdown on physical activity and arrhythmia burden in patients with an implantable cardioverter-defibrillator: the COVID-19 Lockdown ICD-Carelink (CLIC) study

BACKGROUND: Both COVID-19 and the measures taken to control the pandemic may significantly affect cardiovascular health. The effects of a lockdown on physical activity and its potential consequences for arrhythmia burden remain largely unknown. PURPOSE: In this study, we investigated the effect of t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghossein, M A, Linz, D, Van Kraaij, D J W, Van Stipdonk, A M W, De Melis, M, Vernooy, K, Heijman, J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779887/ http://dx.doi.org/10.1093/ehjdh/ztac076.2771

Ejemplares similares

Effects of COVID‐19 lockdown on arrhythmias in patients with implantable cardioverter‐defibrillators in southern Italy
por: Ducceschi, Valentino, et al.
Publicado: (2022)

Implantable cardioverter-defibrillator (ICD) provides an exclusive epidemiological tool for evaluation of the earthquake induced cardiac arrhythmias
por: Ranjbar, Abdolmohammad, et al.
Publicado: (2017)

Psychosocial impact of implantable cardioverter defibrillators (ICD) in young adults with Tetralogy of Fallot
por: Opić, Petra, et al.
Publicado: (2012)

Bridge to avoid ICD implantation with wearable cardioverter defibrillators
por: Zoppo, Franco, et al.
Publicado: (2020)

Evolution of Pacemakers and Implantable Cardioverter Defibrillators (ICDs) in Cardiology
por: Sahu, Palash, et al.
Publicado: (2023)

Impact of the COVID‐19 lockdown on the arrhythmic burden of patients with implantable cardioverter‐defibrillators
por: Sassone, Biagio, et al.
Publicado: (2021)

The Italian subcutaneous implantable cardioverter-defibrillator survey: S-ICD, why not?
por: Botto, Giovanni Luca, et al.
Publicado: (2017)

Predictors of appropriate ICD therapy in patients with implantable cardioverter-defibrillator
por: Dehghani, Mohammad Reza, et al.
Publicado: (2006)

Evolution of extravascular implantable cardioverter-defibrillator therapy for ventricular arrhythmias
por: Römers, Hans, et al.
Publicado: (2022)

Impairment of Quality of Life in Patients with Implanted Subcutaneous Cardioverter Defibrillator (S-ICD) Compared to Implanted Transvenous Cardioverter Defibrillator Therapy
por: Thienel, Manuela, et al.
Publicado: (2022)

Assessing the Cost and Resource Use Impact of Implantable Cardiac Defibrillator Shocks in the UK CareLink Population
por: Llewellyn, Jennifer, et al.
Publicado: (2023)

The walk of life: Remote monitoring provides insights into physical activity during a pandemic
por: Heijman, Jordi, et al.
Publicado: (2021)

Secondary prevention implantable cardioverter-defibrillator (ICD) therapy: value in octogenarians
por: Hauck, Christian, et al.
Publicado: (2021)

Cardiac Status Among Heart Failure Patients With Implantable Cardioverter Defibrillators Before, During, and After COVID-19 Lockdown
por: Lu, Yuan, et al.
Publicado: (2022)

Impact of new X-ray technology on patient dose in pacemaker and implantable cardioverter defibrillator (ICD) implantations
por: van Dijk, Joris D., et al.
Publicado: (2016)

Association of Guideline-Based Medical Therapy with Malignant Arrhythmias and Mortality among Heart Failure Patients Implanted with Cardioverter Defibrillator (ICD) or Cardiac Resynchronization-Defibrillator Device (CRTD)
por: Hasin, Tal, et al.
Publicado: (2021)

Subcutaneous implantable cardioverter-defibrillator (S-ICD) for secondary prevention of sudden cardiac death
por: Kempa, Maciej, et al.
Publicado: (2016)

Lead Abandonment and Subcutaneous Implantable Cardioverter-Defibrillator (S-ICD) Implantation in a Cohort of Patients With ICD Lead Malfunction
por: Russo, Vincenzo, et al.
Publicado: (2021)

Evaluation of the Impact of a Chronic Total Coronary Occlusion on Ventricular Arrhythmias and Long‐Term Mortality in Patients With Ischemic Cardiomyopathy and an Implantable Cardioverter‐Defibrillator (the eCTOpy‐in‐ICD Study)
por: van Dongen, Ivo M., et al.
Publicado: (2018)

Integrated approach for smart implantable cardioverter defibrillator (ICD) device with real time ECG monitoring: use of flexible sensors for localized arrhythmia sensing and stimulation
por: Puri, Munish, et al.
Publicado: (2013)

Need for pacing in patients who qualify for an implantable cardioverter‐defibrillator: Clinical implications for the subcutaneous ICD
por: Kutyifa, Valentina, et al.
Publicado: (2020)

Sex‐specific differences in outcome and risk stratification of ventricular arrhythmias in implantable cardioverter defibrillator patients
por: van der Lingen, Anne‐Lotte C.J., et al.
Publicado: (2021)

Comparison and predictors of implantable cardioverter-defibrillator therapy for primary and secondary prevention
por: Evertz, Reinder, et al.
Publicado: (2023)

Subcutaneous implantable cardioverter-defibrillator generator removal: a multicenter analysis
por: Luker, J, et al.
Publicado: (2023)

Performance of an automated external cardioverter defibrillator for inhospital ventricular malignant arrhythmia
por: Timerman, S, et al.
Publicado: (2003)

Wearable cardioverter defibrillator: A life vest till the life boat (ICD) arrives
por: Francis, Johnson, et al.
Publicado: (2014)

The wearable cardioverter defibrillator as a bridge to reimplantation in patients with ICD or CRT-D-related infections
por: Castro, L., et al.
Publicado: (2017)

Transvenous Implantable Cardioverter‐Defibrillator (ICD) Lead Performance: A Meta‐Analysis of Observational Studies
por: Providência, Rui, et al.
Publicado: (2015)

Ventricular arrhythmias among patients with implantable cardioverter‐defibrillator during the COVID‐19 pandemic
por: Malanchini, G., et al.
Publicado: (2021)

An unusual complication during reimplantation of implantable cardioverter defibrillator (ICD) after ICD leads extraction: Distal migration of anchoring sleeve
por: Korkmaz, Ahmet, et al.
Publicado: (2018)

Physical activity is reduced prior to ventricular arrhythmias in patients with a wearable cardioverter defibrillator
por: Burch, Ashley E., et al.
Publicado: (2019)

Methodological limitations of psychosocial interventions in patients with an implantable cardioverter-defibrillator (ICD) A systematic review
por: Salmoirago-Blotcher, Elena, et al.
Publicado: (2009)

Single-center experience with wearable cardioverter-defibrillator as a bridge before definitive ICD implantation
por: Mugnai, Giacomo, et al.
Publicado: (2019)

Prediction Efficiency of MADIT-ICD Benefit Score for Outcome in Asian Patients with Implantable Cardioverter-Defibrillator
por: Song, Ke, et al.
Publicado: (2022)

Genome-Wide Association of Implantable Cardioverter-Defibrillator Activation With Life-Threatening Arrhythmias
por: Murray, Sarah S., et al.
Publicado: (2012)

Benefit of a wearable cardioverter defibrillator for detection and therapy of arrhythmias in patients with myocarditis
por: Tscholl, Verena, et al.
Publicado: (2021)

Intra-operative defibrillation testing and clinical shock efficacy in patients with implantable cardioverter-defibrillators: the NORDIC ICD randomized clinical trial
por: Bänsch, Dietmar, et al.
Publicado: (2015)

Vectorcardiographic QRS area as a predictor of response to cardiac resynchronization therapy
por: Ghossein, Mohammed A, et al.
Publicado: (2022)

Dutch Outcome in Implantable Cardioverter‐Defibrillator Therapy: Implantable Cardioverter‐Defibrillator–Related Complications in a Contemporary Primary Prevention Cohort
por: van Barreveld, Marit, et al.
Publicado: (2021)

Low efficacy of cardioversion of persistent atrial fibrillation with the implantable cardioverter-defibrillator
por: Limantoro, I., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_aqdsr1p66isesrua5qs2gos6cr